Drénou, B <br/><br/>
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.  [electronic resource] 

 -  Blood  Apr 1997 
 - 2966-74 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--analysis<br/>Adult<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>CD3 Complex--analysis<br/>CD56 Antigen--analysis<br/>Cell Nucleus--ultrastructure<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Etoposide--administration & dosage<br/>Fatal Outcome<br/>Female<br/>Femoral Neoplasms--drug therapy<br/>Herpesvirus 4, Human<br/>Humans<br/>Idarubicin--administration & dosage<br/>Immunophenotyping<br/>Killer Cells, Natural--drug effects<br/>Lymphoma, Large-Cell, Immunoblastic--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Lymphoma, T-Cell--drug therapy<br/>Male<br/>Methylprednisolone--administration & dosage<br/>Neoplasm Invasiveness<br/>Neoplasm Proteins--analysis<br/>Neoplastic Stem Cells--drug effects<br/>Pelvic Neoplasms--drug therapy<br/>Prednisone--administration & dosage<br/>Quinine--administration & dosage<br/>Vincristine--administration & dosage